Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun 4:10:484.
doi: 10.3389/fphar.2019.00484. eCollection 2019.

Cervical Cancer, Different Treatments and Importance of Bile Acids as Therapeutic Agents in This Disease

Affiliations
Review

Cervical Cancer, Different Treatments and Importance of Bile Acids as Therapeutic Agents in This Disease

Tanja Šarenac et al. Front Pharmacol. .

Abstract

Cervical cancer can be cured, because it has a long preinvasive period. Early diagnosis and treatment of cervical cancer at women are crucial for reducing of rate mortality. Today, there are many methods for detecting premalignant lesions and one of them is a conventional Papanicolaou test. Cervical cancer develops through a series of changes in the epithelium called cervical intraepithelial neoplasia (CIN). The biological and genetic characteristics of the cells at cancer in situ are irreversibly altered and abnormal cells have the potential to metastasize to others anatomical regions. Infection with human Papillomavirus, which is transmitted sexually, is considered the main cause and represent the necessary, but not the only factor for the development of cervical cancer. Types of high risk human Papillomavirus are often associated with invasive cervical cancer. The carcinogenic types of HPV 16 and 18 are responsible for 70% of cervical cancer and about 50% of CIN 3. Primary prevention of cervical cancer is aimed at reducing incidence, control of causes and risk factors. In this scientific work, in addition to explaining the various treatments necessary for the treatment of cervical carcinoma, we were discussed about the anticancer effects of the synthetic derivative of ursodeoxycholic acid, such as HS-1183, and synthetic derivatives of chenodeoxycholic acid such as HS-1199 and HS-1200. Also, the effects of bile acid complexes with metals such as platinum, zinc, nickel, and copper were considered in the effective treatment of cervical cancer. KEY POINTS • Lymphogenic spreading of cervical cancer occurs relatively early in the regional lymph nodes, while this sort of progression of cervical cancer is rarer in the juxtaregional (paraaortic), mediastinal and supraclavicular nodes. Clinically proven supraclavicular metastases are not a rarity. In stages IIb and IIIa with metastases in paraaortal nodes occur a 20% metastases at the neck lymph nodes. Hematogenic metastases are relatively rare and occur in the posterior phase. Distant metastases are detected in the lungs and liver. Preinvasive and microinvasive stages of cervical cancer are without symptoms. With deeper invasion of the strome, certain clinical symptoms such as prolonged menstruation, increased vaginal secretions, vaginal bleeding between the two periods, contact bleeding (after coitus), unilateral pelvic pain with spreading in hip joint (infiltration of the pelvic nerve plexus), dysuric disturbance, anemia, islet of the lower extremities. In order to diagnose the level spreading of primary lesion of cervical cancer most commonly are used the supplemental searches such as cytoscopy, rectoscopy, urography, irigography, lung and bone radiography, scintigraphy of the liver, kidney and bone, lymphography, CT (MR) of abdomen and pelvis, as well as laboratory analysis. Surgical treatment consists of transvaginal hysterectomy, transabdominal removal of the uterus (via laparotomy), bilateral adenectomy (removal of the ovaries and the fallopian tubes), upper and middle third of the vagina and lymphonodectomy of the regional lymph nodes. The most commonly used radiotherapy, intracavitary brachytherapy, manual afterloading technique and remote afterloading techniques. The synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid such as HS-1183, HS-1199, and HS-1200 are used to treat cervical cancer. These derivatives of chenodeoxycholic acid and ursodeoxycholic acid are capable of inhibiting cell proliferation and inducing apoptosis in SiHa human cells of cervix. Platinum compounds are used as catalysts in cervical cancer therapy. Clinical use of platinum complexes for which the bile acids bind is based on the desire to achieve the death of tumor cells and the spectrum of drug activity in the treatment of cervical cancer. Bisursodeoxycholate (ethylenediamine) platinum (II) [Pt(UDC)2(en)] is characterized by important cytotoxicity against HeLa cervical carcinoma cells and this effect already being clearly detectable after 24 h.

Keywords: bile acids; cervical cancer; different treatments; therapeutic agents; treatment of cervical cancer.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Persistent Human papillomavirus (HPV) infection leads to the invasive cervical cancer and transient HPV infections pass within 24 months.
FIGURE 2
FIGURE 2
Cone biopsy (conization of the cervix).
FIGURE 3
FIGURE 3
Showing a healthy cervix and cervix with carcinoma.
FIGURE 4
FIGURE 4
Taking a swab from the cervix through the Papanicolaou test.
FIGURE 5
FIGURE 5
Colposcopy as a primary screening test for cervical cancer.
FIGURE 6
FIGURE 6
IA1 IA2, IB1, and IB2 stages of cervical cancer.
FIGURE 7
FIGURE 7
Stages IIA1, IIA2, and IIB of cervical cancer.
FIGURE 8
FIGURE 8
Stages IIIA and IIIB of cervical cancer.
FIGURE 9
FIGURE 9
Stage IVA of cervical cancer.
FIGURE 10
FIGURE 10
Stage IVB of cervical cancer.
FIGURE 11
FIGURE 11
Four stages of cervical carcinoma.
FIGURE 12
FIGURE 12
Abdominal, vaginal and laparoscopic hysterectomy.
FIGURE 13
FIGURE 13
Radical hysterectomy for early stage of cervical cancer.
FIGURE 14
FIGURE 14
Structure of Star CA-PLGA-b-TPGS and Star CA-PLGA.
FIGURE 15
FIGURE 15
Structure of Bisursodeoxycholate (ethylenediamine) platinum.

References

    1. Al-Daraji W. I., Smith J. H. (2009). Infection and cervical neoplasia: facts and fiction. Int. J. Clin. Exp. Pathol. 2 8–64. - PMC - PubMed
    1. Al-Kalbani M., McVeigh G., Nagar H., McCluggage W. G. (2012). Do FIGO stage 1 A and small (≤ 2 cm) 1B1 cervical adenocarcinomas have a good prognosis and warrant less radical surgery? Int. J. Gynecol. Cancer 22 291–295. 10.1097/IGC.0b013e3182339fff - DOI - PubMed
    1. Altgassen C., Hertel H., Brandstädt A., Köhler C., Dürst M., Schneider A. (2008). AGO study group. multicenter validation study of the sentinel lymph node concept in cervical cancer: ago study group. J. Clin. Oncol. 26 2943–2951. 10.1200/JCO.2007.13.8933 - DOI - PubMed
    1. Amaral J. D., Viana R. J. S., Ramalho R. M., Steer C. J., Rodrigues C. M. (2009). Bile acids: regulation of apoptosis by ursodeoxycholic acid. J. Lipid Res. 50 1721–1734. 10.1194/jlr.R900011-JLR200 - DOI - PMC - PubMed
    1. American Joint Committee on Cancer [AJCC] (2017). Cervix Uteri in AJCC Cancer Staging Manual 8th Edn. New York, NY: Springer; 649–659.